Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
NCT04028856
·
clinicaltrials.gov ↗
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
interferon
Sponsor
Beijing Ditan Hospital